Related Experiment Video

Updated: Oct 15, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

365

KCa3.1 in diabetic kidney disease

Chunling Huang1, Xin-Ming Chen, Carol A Pollock

  • 1Kolling Institute, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia.

Current Opinion in Nephrology and Hypertension
|October 28, 2021
PubMed
Abstract

Insights

Targeting the KCa3.1 channel may offer a new treatment for diabetic kidney disease (DKD). Inhibiting KCa3.1 improves mitochondrial function and reduces inflammation, potentially slowing DKD progression.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pharmacology

Background:

  • Diabetic kidney disease (DKD) poses a significant health challenge with limited treatment options.
  • Mitochondrial dysfunction is a key factor in DKD development and progression.
  • The KCa3.1 potassium channel is implicated in cellular processes relevant to DKD.

Purpose of the Study:

  • To review the pathophysiological roles of the KCa3.1 channel in DKD.
  • To examine the involvement of KCa3.1 in mitochondrial function within the context of DKD.
  • To discuss the therapeutic potential of targeting KCa3.1 for DKD treatment.

Main Methods:

  • Literature review of studies on KCa3.1 channel function in DKD.
  • Analysis of research linking KCa3.1 dysregulation to mitochondrial dysfunction.
  • Evaluation of evidence for KCa3.1 inhibition as a therapeutic strategy.

Main Results:

  • KCa3.1 dysregulation contributes to mitochondrial dysfunction, inflammation, and fibrosis in DKD.
  • KCa3.1 deficiency ameliorates diabetes-induced mitochondrial issues by improving mitochondrial dynamics and mitophagy.
  • Pharmacological inhibition of KCa3.1 shows promise in preclinical models of DKD.

Conclusions:

  • Targeting KCa3.1 represents a potential novel therapeutic strategy for DKD.
  • Inhibiting KCa3.1 may address key pathological mechanisms including fibrosis, inflammation, and mitochondrial dysfunction.
  • Repurposing senicapoc, a KCa3.1 inhibitor with a known safety profile, could accelerate new DKD drug development.

More Related Videos

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.3K
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.3K

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
116
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
162
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
84
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
157
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
87
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
68